116
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Early Prediction for Persistent Inflammation-Immunosuppression Catabolism Syndrome in Surgical Sepsis Patients

, , , , , , , & show all
Pages 5441-5448 | Published online: 09 Sep 2021

References

  • Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
  • Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a National Cross-Sectional Survey. Crit Care Med. 2020;48(3):e209–e18. doi:10.1097/CCM.0000000000004155
  • Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318(13):1241–1249. doi:10.1001/jama.2017.13836
  • White LE, Chaudhary R, Moore LJ, et al. Surgical sepsis and organ crosstalk: the role of the kidney. J Surg Res. 2011;167(2):306–315. doi:10.1016/j.jss.2010.11.923
  • Bateman BT, Schmidt U, Berman MF, et al. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample. Anesthesiology. 2010;112:917–925. doi:10.1097/ALN.0b013e3181cea3d0
  • Milano PK, Desai SA, Eiting EA, et al. Sepsis bundle adherence is associated with improved survival in severe sepsis or septic shock. West J Emerg Med. 2018;19:774–781. doi:10.5811/westjem.2018.7.37651
  • van Zanten AR, Brinkman S, Arbous MS, et al. Guideline bundles adherence and mortality in severe sepsis and septic shock. Crit Care Med. 2014;42:1890–1898. doi:10.1097/CCM.0000000000000297
  • Brakenridge SC, Efron PA, Cox MC, et al. Current epidemiology of surgical sepsis: discordance between inpatient mortality and 1-year outcomes. Ann Surg. 2019;270(3):502–510. doi:10.1097/SLA.0000000000003458
  • Stortz JA, Murphy TJ, Raymond SL, et al. Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis. Shock. 2018;49(3):249–258. doi:10.1097/SHK.0000000000000981
  • Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;45(2):253–262. doi:10.1097/CCM.0000000000002074
  • Gardner AK, Ghita GL, Wang Z, et al. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs. Crit Care Med. 2019;47(4):566–573. doi:10.1097/CCM.0000000000003655
  • Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581–2590. doi:10.1084/jem.20111354
  • Yang N, Li B, Ye B, et al. The long-term quality of life in patients with persistent inflammation-immunosuppression and catabolism syndrome after severe acute pancreatitis: a retrospective cohort study. J Crit Care. 2017;42:101–106. doi:10.1016/j.jcrc.2017.07.013
  • Hu D, Ren J, Wang G, et al. Persistent inflammation-immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit. J Trauma Acute Care Surg. 2014;76:725–729. doi:10.1097/TA.0b013e3182aafe6b
  • Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309–318. doi:10.1093/cid/cit816
  • Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
  • Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–1501. doi:10.1097/TA.0b013e318256e000
  • Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, et al. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014;76:21–9; discussion 9–30. doi:10.1097/TA.0b013e3182ab1ab5
  • Brusselaers N, Lagergren J. The Charlson Comorbidity Index in registry-based research. Methods Inf Med. 2017;56:401–406. doi:10.3414/ME17-01-0051
  • Price CL, Knight SC. Methylglyoxal: possible link between hyperglycaemia and immune suppression? Trends Endocrinol Metab. 2009;20(7):312–317. doi:10.1016/j.tem.2009.03.010
  • Bozinovski S, Vlahos R, Anthony D, et al. COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link. Br J Pharmacol. 2016;173(4):635–648. doi:10.1111/bph.13198
  • Zhang Y, Bauersachs J, Langer HF. Immune mechanisms in heart failure. Eur J Heart Fail. 2017;19(11):1379–1389. doi:10.1002/ejhf.942
  • Sinapidis D, Kosmas V, Vittoros V, et al. Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection. BMC Infect Dis. 2018;18(1):242. doi:10.1186/s12879-018-3156-z
  • Furman D, Campisi J, Verdin E. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–1832. doi:10.1038/s41591-019-0675-0
  • Berger MM, Reintam-Blaser A, Calder PC, et al. Monitoring nutrition in the ICU. Clin Nutr. 2019;38(2):584–593. doi:10.1016/j.clnu.2018.07.009